Abiopharma

🔍 YANG MICHAEL J. (Director)

Company: IONIS PHARMACEUTICALS INC (IONS)

Report Date: 2026-01-15

Detailed Transactions and Holdings:

• Acquired 1,930 shares of Common Stock (Direct)
  Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,940.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 1,930 shares of Restricted Stock Unit (Derivative)
  Date: 2026-01-15 | Code: M | Exercise: 2026-01-15 | equity_swap_involved: 0 | shares_owned_after: 7,150.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
• F2: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
• F3: Restricted Stock Units vest in three equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.